Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis.
Percutaneous renal artery stenting has become the treatment of choice for renal artery stenosis. In-stent restenosis (ISR) still remains a persistent problem. Drug eluting stents have significantly reduced the incidence of ISR in coronary arteries. We report a case in which recurrent renal ISR was successfully treated with paclitaxel-eluting stent implantation, using intravascular ultrasound guidance, with maintained stent patency at 6 months.
Kakkar
Aman K
AK
Cardiology Unit, University of Rochester Medical Center, NY 14642, USA.
Fischi
Michael
M
Narins
Craig R
CR
D000792:Angiography; D000800:Angioplasty, Balloon; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012078:Renal Artery Obstruction / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D015607:Stents; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional; D014654:Vascular Patency
D017239:Paclitaxel